Purdue Pharma L.P. Presents Data from Research Studies at American Pain Society 33rd Annual Scientific Meeting

Stamford, Conn. – April 29, 2014 – Purdue Pharma L.P. will present results from a number of research studies at the American Pain Society (APS) 33rd Annual Scientific Meeting, April 30-May 3, 2014, in Tampa, Fla.

Following is a schedule of select poster presentations:

TITLE

AUTHORS

DATE / TIME

A Single-Center, Randomized, Double-Blind Crossover Study to Evaluate the Abuse Potential, Pharmacokinetics, and Safety of Milled and Intranasally Administered Extended-Release Hydrocodone in Recreational Opioid Users

Harris S, Colucci S, Perrino P, Kapil R, Geoffroy P, Hopyan T, Levy-Cooperman N

Thursday, May 1,
9:30 AM–11:00 AM

A Single-Center, Randomized, Double-Blind, Crossover Study to Evaluate the Abuse Potential, Pharmacokinetics, and Safety of Oral Milled and Intact Extended-Release Hydrocodone (HYD) Tablets in Recreational Opioid Users

Harris S, Colucci S, Perrino P, Kapil R, Geoffroy P, Hopyan T, Levy-Cooperman N

Friday, May 2,
8:45 AM-10:15 AM

Long-term Safety and Effectiveness of Once-daily, Single-entity, Abuse-deterrent Hydrocodone in Chronic Nonmalignant and Nonneuropathic Pain: Results of a Long-term Open-label Study

Wen W, Taber L, Lynch SY, Munera C, Ripa SR

Thursday, May 1,
9:30 AM–11:00 AM

In Vitro Assessment of the Effects of Alcohol on the Release Rate of Hydrocodone Bitartrate from a Once-daily, Single-Entity, Hydrocodone Bitartrate Formulation

Giordano J, Huang H, Kianto J

Friday, May 2,
8:45 AM-10:15 AM

Comparison of the Risk of Opioid Overdose among Patients Prescribed Immediate-Release and Extended-Release Opioid Analgesics

Coplan P, DeVeaugh-Geiss A, Kadakia A

Thursday, May 1,
9:30 AM–11:00 AM

Abuse-deterrent Opioid Analgesic Formulations: Technology, Evaluation, and Labeling

Haddox D

Friday, May 2,
8:45 AM – 10:15 AM

Impact of an opioid reformulation with abuse-deterrent properties on doctor-shopping

Chilcoat H, Coplan PM, Sessler NE, Schultz Y, Yuan Y

Friday, May 2,
8:45 AM – 10:15 AM

Epidemiology of Conditions Associated with Pain and the Use of Analgesic and Non-Analgesic Treatments in Pediatrics

Wallace L, Baldridge S, Matsuno R

Thursday, May 1,
9:30 AM – 11:00 AM

Neonatal Abstinence Syndrome in Commercially-insured and Medicaid Patients: Differences in Patient and Maternal Characteristics and Outpatient Treatment Patterns

Wallace L, Harding B, Matsuno RK

Thursday, May 1,
9:30 AM – 11:00 AM

About Purdue Pharma L.P.

Purdue Pharma L.P. and its associated U.S. companies are privately-held pharmaceutical companies known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.

#   #   #

Contact:

James Heins
Senior Director, Public Affairs
office: 203-588-8069
mobile: 203-856-2121
Email: james.heins@pharma.com

Jennifer Soares
Senior Manager, Corporate Affairs & Communications
office: 203-588-7623
mobile: 203-609-1746
email: jennifer.soares@pharma.com